Cancer Stem Cell Marker Phenotypes are Reversible and Functionally Homogeneous in a Preclinical Model of Pancreatic Cancer

Por Dosch, Joseph S., Ziemke, Elizabeth K., Shettigar, Amrith, Rehemtulla, Alnawaz, Sebolt-Leopold, Judith S.
Publicado no Cancer Res (2015)

Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6

Por Ziemke, Elizabeth K., Dosch, Joseph S., Maust, Joel D., Shettigar, Amrith, Sen, Ananda, Welling, Theodore H., Hardiman, Karin M., Sebolt-Leopold, Judith S.
Publicado no Clin Cancer Res (2015)

Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells

Por Stacer, Amanda C., Wang, Hanxiao, Fenner, Joseph, Dosch, Joseph S., Salomonnson, Anna, Luker, Kathryn E., Luker, Gary D., Rehemtulla, Alnawaz, Ross, Brian D.
Publicado no Mol Imaging (2015)

Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow

Por Cavnar, Stephen P., Rickelmann, Andrew D., Meguiar, Kaille F., Xiao, Annie, Dosch, Joseph, Leung, Brendan M., Cai Lesher-Perez, Sasha, Chitta, Shashank, Luker, Kathryn E., Takayama, Shuichi, Luker, Gary D.
Publicado no Neoplasia (2015)

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

Por Dosch, Joseph, Ziemke, Elizabeth, Wan, Shanshan, Luker, Kathryn, Welling, Theodore, Hardiman, Karin, Fearon, Eric, Thomas, Suneetha, Flynn, Matthew, Rios-Doria, Jonathan, Hollingsworth, Robert, Herbst, Ronald, Hurt, Elaine, Sebolt-Leopold, Judith
Publicado no Oncotarget (2017)

The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling

Por Nyati, Shyam, Schinske-Sebolt, Katrina, Pitchiaya, Sethuramasundaram, Chekhovskiy, Katerina, Chator, Areeb, Chaudhry, Nauman, Dosch, Joseph, Van Dort, Marcian E., Varambally, Sooryanarayana, Kumar-Sinha, Chandan, Nyati, Mukesh Kumar, Ray, Dipankar, Walter, Nils G., Yu, Hongtao, Ross, Brian Dale, Rehemtulla, Alnawaz
Publicado no Sci Signal (2015)